PTEN Activity Is Modulated During Ischemia and Reperfusion
- 9 December 2005
- journal article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 97 (12) , 1351-1359
- https://doi.org/10.1161/01.res.0000195656.52760.30
Abstract
Ischemic preconditioning (IPC), a brief period of ischemia and reperfusion (I/R), generates profound but transient protection against a subsequent prolonged ischemic episode. The serine-threonine kinase Akt has been shown to mediate IPC, and Akt activation is negatively regulated by the phosphatase PTEN, but whether PTEN activity is modulated by IPC has not been investigated. When isolated, perfused rat hearts were subjected to an IPC stimulus consisting of 15-minute ischemia and 30-minute reperfusion (I-15/R-30), PTEN protein levels and activity were decreased, and levels of phospho-AKT were increased, relative to nonischemic hearts. Hearts subjected to IPC demonstrated improved recovery of cardiac function when subsequently subjected to I-30/R-45 as compared with hearts subjected to I-30/R-45 without prior IPC. When hearts were subjected to I-15 followed by R-30, R-60, or R-120, PTEN reaccumulated gradually and its activity was restored. Phospho-Akt levels at R-120 were decreased and these hearts were no longer protected against injury when subjected to I-30/R-45. Wortmannin administration during reperfusion blocked Akt activation and PTEN reaccumulation. In ischemic hearts, PTEN was rapidly degraded. Pretreatment with proteasome inhibitor MG132 blocked ischemia-induced degradation of PTEN and blocked IPC. Reperfusion following I-15 induced oxidation of the remaining PTEN, leading to Akt activation. Perfusion of H2O2 was sufficient to induce Akt activation. Thus, loss of PTEN activity leads to induction of IPC and feedback mechanisms designed to ensure that Akt activation is transient are responsible for decay of IPC.Keywords
This publication has 34 references indexed in Scilit:
- The Major Target of the Endogenously Generated Reactive Oxygen Species in Response to Insulin Stimulation Is Phosphatase and Tensin Homolog and Not Phosphoinositide-3 Kinase (PI-3 Kinase) in the PI-3 Kinase/Akt PathwayMolecular Biology of the Cell, 2005
- Preclinical and clinical development of the proteasome inhibitor bortezomib in cancer treatmentDrugs of Today, 2005
- Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathwayJournal of Neurochemistry, 2004
- The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and diseaseJournal of Molecular and Cellular Cardiology, 2004
- Regulation of Cell Size and Contractile Function by AKT in CardiomyocytesAnnals of the New York Academy of Sciences, 2004
- Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion InjuryCirculation, 2003
- Glycogen Synthase Kinase-3βCirculation Research, 2002
- The Tumor Suppressor Gene PTEN Can Regulate Cardiac Hypertrophy and SurvivalJournal of Biological Chemistry, 2001
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Preconditioning ischemia time determines the degree of glycogen depletion and infarction size reduction in rat heartsAmerican Heart Journal, 1996